Scotts Valley, CA, United States of America

Alison Witte

USPTO Granted Patents = 26 (Patent Applications = 6)

CIPO Patents = 5

EPO Patents = 12 (Patent Applications = 5)

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 135(Granted Patents)

Location History:

Scotts Valley, CA (US) (2008 - 2019)
Rogue River, OR (US) (2015 - 2021)

Company Filing History:

E. R. Squibb Sons, Inc.

Bristol-myers Squibb Compnay

patents

where one patent can have more than one assignee

Years Active: 2008-2021

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11072664 - Interferon receptor 1 antibodies and their uses (2021-07-27),

2. 10385133 - Interferon receptor 1 antibodies and their uses (2019-08-20),

3. 10358490 - Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodies (2019-07-23),

4. 9988453 - Human monoclonal antibodies to O8E (2018-06-05),

5. 9783606 - Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodies (2017-10-10),

6. 9765141 - Methods for preparing interferon alpha antibodies (2017-09-19),

7. 9631025 - Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies (2017-04-25),

8. 9534053 - Therapeutic human anti-IL-1R1 monoclonal antibody (2017-01-03),

9. 9499632 - Human antibodies that bind CD22 and uses thereof (2016-11-22),

10. 9453077 - Interferon receptor 1 antibodies and their uses (2016-09-27),

11. 9296822 - Human monoclonal antibodies to O8E (2016-03-29),

12. 9138475 - Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM1 antibodies (2015-09-22),

13. 8945553 - Bispecific antibodies to IL-23 and IL-17A/F (2015-02-03),

14. 8722870 - Nucleic acids encoding interferon alpha antibodies (2014-05-13),

15. 8710203 - Therapeutic human anti-IL-1R1 monoclonal antibody (2014-04-29),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can help you with that. Here is the article about inventor Alison Witte:

Title: Alison Witte: A Pioneering Innovator in Biomedical Research

Introduction:

Alison Witte is a prominent inventor based in Scotts Valley, CA, with an impressive portfolio of 26 patents to her name. She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies for treating various diseases.

Latest Patents:

Alison Witte's latest patents focus on Interferon receptor 1 antibodies and their uses. These patents provide isolated human monoclonal antibodies that target IFNAR-1, effectively inhibiting the biological activity of Type I interferons. Immunoconjugates, bispecific molecules, and pharmaceutical compositions comprising these antibodies offer novel treatment options for autoimmune disorders, transplant rejection, and Graft Versus Host Disease.

Career Highlights:

Throughout her career, Alison Witte has garnered experience working with leading companies in the pharmaceutical industry. She has been associated with Medarex Inc. and Bristol-Myers Squibb Company (formerly E.R. Squibb & Sons, L.L.C.), showcasing her expertise in drug development and biotechnology.

Collaborations:

Alison Witte has collaborated with esteemed professionals in her field, including Josephine M. Cardarelli and Haichun Huang. Together, they have pioneered research projects that have shaped the landscape of biomedical innovation.

Conclusion:

Alison Witte's groundbreaking work in the development of Interferon receptor 1 antibodies underscores her commitment to advancing medical science and improving patient outcomes. Her patents reflect her dedication to innovation and her profound impact on the healthcare industry.

If you require further information or details on Alison Witte's inventions and patents, feel free to explore our website idiyas.com for comprehensive insights.

This text is generated by artificial intelligence and may not be accurate.